Navigation Links
Outcomes of cartilage tympanoplasty in the pediatric population

Alexandria, VA Cartilage tympanoplasty can be performed successfully in 95 percent of young children when appropriate conditions exist, according to a study in the February 2013 issue of OtolaryngologyHead and Neck Surgery.

"Pediatric tympanoplasty is a frequently performed procedure with varying reported success rates ranging between 35 percent and 94 percent. In general, tympanic membrane repair success in children is often perceived as lagging behind what is typically achieved in adults having similar underlying risk factors," the authors write.

The study was conducted at the University of Arkansas for Medical Sciences in Little Rock, AR. One hundred and nineteen pediatric patients who underwent type I cartilage tympanoplasty to repair a tympanic membrane perforation from August 2005 to November 2011 were divided into three age groups: under 7, 7-9, and 10-13 years old.

The success rates for the three groups were 93 percent, 95 percent, and 97.2 percent, respectively. Statistical analysis was used to test the differences among age groups in regard to remnant perforation, the need for revision tympanoplasty, and the need for tympanoplasty tubes.

The study had an average success rate of 95 percent among the three groups. Repair rates improved, and significant impairments in hearing outcomes were avoided. If tympanoplasty is scheduled accurately, concluded the authors, the age of the patient does not affect the rate of tympanic membrane repair or hearing outcomes.

In summary, the results of the study were promising, and the authors determined that "the use of cartilage in pediatric type I tympanoplasty for tympanic membrane perforation repair results in excellent outcomes that are comparable to the best-case outcomes that have been reported in the adult population."


Contact: Mary Stewart
American Academy of Otolaryngology - Head and Neck Surgery

Page: 1

Related biology news :

1. Women must do more to reap same positive health outcomes as men, MU research suggests
2. Study finds voter genetics may predict election outcomes
3. Early detection techniques offer hope for improved outcomes in lung cancer patients
4. Duke researchers engineer cartilage from pluripotent stem cells
5. Nanoscale scaffolds and stem cells show promise in cartilage repair
6. Pediatric coding top tips and pediatric CPT changes 2013
7. CHOP and BGI strengthen partnership with agreement on pediatric brain tumor collaboration
8. Engineered immune cells produce complete response in child with an aggressive pediatric leukemia
9. Nanotechnology drug delivery shows promise for treatment of pediatric cancer
10. Webcast alert: Molecular Medicine Institute to give new hope to pediatric patients
11. Study shows long-term effects of radiation in pediatric cancer patients
Post Your Comments:
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... of medical marijuana products targeting the needs of consumers who are incorporating medical ... takes place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, ...
Breaking Biology Technology: